May 06, 2017
1 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: SightLife Surgical announces two major partnerships
LOS ANGELES – SightLife Surgical announced partnerships with Imprimis and Shigeru Kinoshita, MD, PhD, President and CEO Monty Montoya said at the Ophthalmology Innovation Summit at ASCRS here. Under the Imprimis agreement the companies will work together to offer autologous Serum Tears across the United States. The goal of the latter agreement is to develop Kinoshita’s injectable endothelial therapy and bring it to the U.S.